Presales Surge Masks Profit Stall—Margin Recovery Unproven
Revenue jumped 40.7% YoY and presales soared 129%, yet net profit fell 18.6%. Management raised guidance mid-cycle while delivering below it. The quarter hinges on one question: can JDA expansion recover margins, or is debt-funded growth obscuring profitability weakness?
₹700 Cr
+129% YoY vs ₹306 Cr Q1 FY26
₹527 Cr
+40.7% YoY, exceeds 20% FY27 guidance
₹70 Cr
+70% YoY, margin 13%
₹13.4 Cr
−18.6% YoY
17-19%
raised from 16-18%; Q1 delivered 13%
₹47 Cr
FY27 target ₹100-120 Cr
On the surface, this is a growth story: presales up 129%, revenue up 40.7%, EBITDA up 70%. But there is a chasm between the headline and the earnings. Net profit fell 18.6% in a quarter where gross profit doubled. The culprit is brutal: interest cost. Management burnt ₹47 crore in Q1 alone — a run-rate that would consume nearly half of the full-year EBITDA guidance. That gap — between a presales surge and a profit stall — is the quarter.
What the numbers say
Start with EBITDA: ₹70 crore, up 70% YoY. That's real. The margin, 13%, is healthy for early-stage project ramp. But subtract the interest burden — ₹47 crore in Q1 — and you're left with ₹23 crore in profit before tax and other items. Add taxes and you get ₹13.4 crore net profit. The math is inescapable: revenue growth is being captured at the EBITDA line, but rising debt service is vaporizing it at net profit. This is the signature of a growth story funded by leverage, not organic cash generation.
Presales ₹700 Cr, 129% YoY growth
₹700 Cr vs ₹306 Cr Q1 FY26; growth confirmed
Supported
Revenue ₹536 Cr, 37% YoY growth
₹527 Cr delivered, +40.7% YoY
Supported (beat by 3.7pp)
EBITDA ₹70 Cr, 70% YoY, margin 13%
₹70 Cr EBITDA (+70% YoY) confirmed; margin 13% vs 11% prior
Supported
FY27 EBITDA margin 17-19% (raised from 16-18%)
Q1 delivered 13%; 400-600 bps gap to guidance
Overstated
PAT growth will follow EBITDA + revenue momentum
Revenue +40.7% but PAT −18.6% YoY; interest ₹47 Cr eroded profit
Contradicted
Net debt-to-equity 0.7x, financial discipline maintained
0.7x confirmed; below 1.0x internal target
Supported
What changed on this call
Guidance raised mid-cycle. EBITDA margin guidance was lifted from 16-18% to 17-19%, yet Q1 delivered only 13%. Management attributed the gap to early-stage JDA project costs; claims recovery will follow in Q2-Q4 as construction crosses revenue-recognition thresholds. This is credibility-dependent: if Q2 margin stays at 13-14%, the full-year guidance is at risk.
JDA presales now 64% of the mix. Of ₹700 Cr Q1 presales, ₹448 Cr (64%) came from 8 JDA projects; owned land (Thane) contributed ₹252 Cr (36%). This is a strategic shift toward a capital-efficient model — 10-15% land deposit vs. 25%+ upfront for owned land acquisitions. It reduces dilution risk but increases execution dependency on partner cooperation.
Debt surged 189% YoY. Gross debt jumped from ₹380 Cr (Q1 FY26) to ₹1,095 Cr (Q1 FY27), funding JDA expansion and Parel acquisition (₹8.5k Cr GDV). Management expects debt to remain elevated for another 1-2 years before moderating as projects mature. This explains the interest cost trajectory: ₹47 Cr Q1 → ₹100-120 Cr FY27 expected.
PAT guidance withdrawn. Unlike prior calls, management refused to quantify FY27 net profit guidance. When pressed, the MD deflected: 'All this money is going towards growth. Once we reach steady state, the debt level will also start to moderate.' Translation: profit visibility is poor amid cost/interest headwinds. This is a red flag for holders accustomed to earnings-per-share clarity.
Institutional investor exodus continues. FII holdings fell from 15.52% (Q1 FY26) to 5.85% (Q1 FY27); DII from 6.35% to 2.89%. Management blamed post-demerger size constraints (FII/DII have minimum market-cap thresholds). Retail and family offices filled the gap. This limits capital-raise flexibility and equity-dilution hedges, forcing continued reliance on debt.
The street's view
The market has a clear opinion. The stock announced the result on August 7 at ₹690 pre-result. By day 1, it had fallen 12%; by day 3, −15.81%; by day 5, −15.67%. The move was decisive and sticky — no rebound. The selloff wasn't a momentary shock; it was a repricing of the profit risk.
Price action confirms the fundamental concern: presales alone don't justify the valuation if profit is stalled. At ₹577.8 today, the stock is down 21.38% from its all-time high and has fallen below both the 20-day and 50-day moving averages. The RSI of 28.9 is technically oversold — a sign of capitulation selling. Yet volume has been increasing, suggesting institutional and HNI exits are structural, not panic.
Bulk/block trades show some institutional buying near ₹630-636 (NK Securities, Junomoneta, DIPAN Mehta Commodities), but dominant selling from brokerages (QE Securities, IRAGE) at similar levels. The net flow is ambiguous — no clear conviction in either direction among large players. This is a market waiting for direction.
Presales +129% YoY; demand validated in Mumbai premium segment
Revenue +40.7% YoY; collection momentum ₹550 Cr (+47% YoY) strong
₹52k Cr GDV pipeline, 7-8 year visibility, capital-efficient JDA model (64% of presales)
Net debt-to-equity 0.7x; financial discipline vs 1.0x target
New IR head (Sumeet Sabharwal) hired; institutional outreach ongoing
PAT fell 18.6% YoY despite revenue +40.7%; profit lagging growth
Interest cost ₹47 Cr Q1 is 67% of EBITDA; FY27 ₹100-120 Cr will consume 33-40% of EBITDA
EBITDA margin 13% vs 17-19% guidance; 400-600 bps gap unproven
PAT guidance withdrawn; management refuses to quantify profit path
Gross debt ₹1,095 Cr (+189% YoY); elevated for next 1-2 years
FII/DII holdings fell 22% → 8% over 4 quarters; institutional confidence eroding
Stock down 21.38% from ATH, RSI 28.9 oversold; market repriced profit risk
Profitability stalled by interest burden
HighRevenue +40.7% but PAT −18.6%. Interest ₹47 Cr Q1 (₹100-120 Cr FY27) consumes 33-40% of EBITDA guidance. If EBITDA misses or debt rises further, profit will sink. Management's silence on PAT is ominous.
EBITDA margin recovery unproven
HighQ1 delivered 13% vs 17-19% FY27 target (400-600 bps gap). Management claims early-stage project costs suppress margins; recovery expected Q2-Q4. If Q2 margins stay 12-14%, full-year guidance is missed and credibility erodes further.
Debt trajectory unsustainable near-term
HighGross debt ₹1,095 Cr (+189% YoY), expected to stay elevated 1-2 more years. If presales slow, collection falters, or interest rates rise, debt-service pressure will spike. D/E 0.7x is healthy but trajectory is steep.
Institutional investor exodus limits capital flexibility
MediumFII+DII fell 22% → 8% over 4 quarters. Limits equity-raise capacity; forces continued debt reliance. If a major shortfall emerges, limited institutional buyers = higher dilution or forced asset sales.
Project execution delays (Mahim Q3-Q4, Parel 18 months)
MediumMonsoon season complicates Q3 launches; approvals still pending for Parel. If Mahim launches slip to Q4 or Parel timeline extends, H2 FY27 presales/revenue will disappoint.
Margin guidance raised while delivering below target
MediumManagement raised EBITDA guidance mid-cycle (16-18% → 17-19%) despite Q1 missing. If this pattern repeats, market will stop believing guidance and re-rate the stock lower.
1 · Q2 EBITDA margin trajectory
Is 13% a trough or a floor? If Q2 margin improves to 14-15%+, the path to 17-19% FY27 guidance becomes credible. If it stays 12-14%, full-year guidance is at risk and profit growth remains stalled. This is the quarter's lynchpin.
2 · Collections & cash conversion
Q1 collections ₹550 Cr (+47% YoY) are strong, but debt is rising faster. Monitor cash realization from presales. If collections momentum falters (< 40% YoY growth in H2), then presales-to-revenue visibility weakens and debt-service pressure rises.
3 · Mahim launches (Q3-Q4) execution
Mahim-1 (₹2,500 Cr GDV) targeted for Nov-Dec 2026 (Q3); Mahim-2 (₹2,100+ Cr) for Q4. Monsoon season risk is acknowledged but minor per management. Monitor approval/construction progress. Any slip to next quarter compresses FY27 presales and defers margin recovery.
4 · Interest cost & debt growth rate
Q1 interest ₹47 Cr annualizes to ~₹188 Cr, yet management guided ₹100-120 Cr FY27. If absolute debt continues rising > 5% per quarter, annual interest could exceed guidance and profit will disappoint further. Track Q2-Q3 absolute debt levels.
5 · Institutional investor sentiment & re-entry
New IR head hired (Sumeet Sabharwal); market-cap growth to ₹4k+ Cr may unlock FII/DII re-entry (size-limit thresholds). Monitor bulk/block trading for institutional buying. If FII/DII re-accumulate, stock will stabilize; continued exodus signals loss of confidence.
This is a steady, capital-efficient growth story — JDA model is sound, presales momentum is real, pipeline is massive. But execution risk is high: margin recovery unproven, profit lagging despite revenue growth, interest burden rising, guidance raised mid-cycle while missing. The market's 15-21% drawdown is justified. At ₹577, the stock is technically oversold (RSI 28.9) and below key moving averages — a potential tactical bounce if Q2 EBITDA margins surprise to the upside. But the fundamental concern (profit stalled by debt service) is real, not transient.
For holders: this is a hold-and-wait quarter. Credibility hinges on Q2 margin recovery and Q3-Q4 project execution. For new buyers: wait for either a Q2 EBITDA beat or further price weakness to ₹520-540 (a 15-20% additional discount) to add at better risk-reward.
The number to track from here: Q2 EBITDA margin. If it's 14%+, the recovery narrative holds. If it's 12-13%, presales momentum was real, but profitability risk persists and the stock will re-test lows.
Informational and educational content only. Not investment advice.